Skip to content
Review Open access

Oxidative stress as a driver of organelle cascade damage in neurological diseases

Jul 2026 · Frontiers in Aging Neuroscience · Vol 18 · 0 citations · 60 references
Medicine

TL;DR

This review integrates current studies, clarifies context-dependent and disease-specific characteristics of organelle interactions, and discusses potential therapeutic strategies with critical consideration of translational challenges and limitations, providing a theoretical foundation for mechanistic research and clinical intervention of neurological diseases.

Abstract

As a core driver in the pathological progression of neurological diseases, oxidative stress contributes to the onset and development of multiple disorders, including traumatic brain injury (TBI), Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), by inducing interconnected and bidirectional damage among mitochondria, endoplasmic reticulum, lysosomes, and the nucleus. This review systematically summarizes the oxidative stress-mediated inter-organelle crosstalk network: Mitochondria act as one of the earliest and central hubs, and their dysfunction (e.g., reactive oxygen species burst, calcium overload, and respiratory chain impairment) induces endoplasmic reticulum stress via ROS diffusion and calcium signaling disturbance. The disruption of endoplasmic reticulum calcium homeostasis further exacerbates mitochondrial damage, forming a vicious cycle. Lysosomes exhibit reduced membrane stability and impaired autophagic flux under oxidative stress, failing to clear damaged organelles and aggravating oxidative stress accumulation. Ultimately, oxidative stress signals are transmitted to the nucleus, resulting in DNA damage, aberrant epigenetic modifications, and activation of pro-inflammatory/pro-apoptotic genes, thereby accelerating disease progression. Notably, this organelle injury transmission is not a rigid unidirectional linear cascade; primary lysosomal or MAM defects can independently initiate the full organelle damage loop without preceding mitochondrial dysfunction. This review integrates current studies, clarifies context-dependent and disease-specific characteristics of organelle interactions, and discusses potential therapeutic strategies with critical consideration of translational challenges and limitations, providing a theoretical foundation for mechanistic research and clinical intervention of neurological diseases.

Read PDF

Similar papers

Review Open access Sep 2026

PERK signalling in neurodegenerative diseases: From ER stress to mitochondrial dysfunction and therapeutic opportunities

The activation mechanisms of the PERK pathway in diseases such as Alzheimer’s disease and Parkinson’s disease are reviewed, focusing on its role as a molecular bridge that converts endoplasmic reticulum stress into mitochondrial dysfunction.

Tao Xu, Sheng-Wei Jing, Jing Wu · 0 citations
Review Open access Aug 2026

Oxidative stress and inflammation in neurodegenerative disorders

Several promising epidemiological trials linked high dietary intake of vitamins C and E to a reduced risk of Parkinson’s disease, and plant-derived antioxidants such as polyphenols were explored for their ability to combat neuroinflammation and reduce cognitive decline.

K. Jomová, S. Alomar, Richard Valko et al. · 0 citations
Review Open access Aug 2026

MicroRNA–Ferroptosis–Spinal Cord Injury: A Complex Interplay in Neurodegeneration and Repair

Current evidence on the molecular mechanisms linking miRNAs and ferroptosis in SCI is summarized, highlighting how miRNA-mediated regulation of ferroptosis contributes to neuronal death, glial responses, and impaired regeneration, and discusses emerging therapeutic strategies targeting this axis to promote neuroprotect...

Raju Poongodi, Tao-Hsiang Yang, Kuender D. Yang et al. · 0 citations
Review Open access Sep 2026

Oxidative Stress and Mitochondrial Dysfunction in Chronic Kidney Disease: From Molecular Mechanisms to Biomarkers and Targeted Therapies

This review emphasizes not only mechanistic advances but also conflicting findings, model limitations, and the barriers that currently separate experimental efficacy from clinically meaningful CKD outcomes.

F. De Luca, Dario Troise, Valentina Camporeale et al. · 1 citation
Review Sep 2026

The redox paradox in neurological disorders: balancing cytoprotection, ferroptosis, and therapeutic targeting.

A contextual framework is built that specifies when HO-1 activation is protective versus detrimental, organised around three converging determinants: cell-type specificity, iron-handling capacity, and disease stage, which is extended to the often-overlooked dimensions of sex, age, and model heterogeneity, and used to i...

Tanvi Premchandani, M. Qutub, Tejaswini Thave et al. · 1 citation
Review Open access Aug 2026

Iron dysregulation: implications for pathology in multiple sclerosis

This review provides a comprehensive overview of iron biology, emphasizing its chemical properties, cellular functions, and the tightly regulated mechanisms that maintain iron homeostasis and the pathological consequences of iron dysregulation in multiple sclerosis.

Dorsa Moezzi, R. Gorter, Atefeh Rayatpour et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.